1-14 of 14
Nicholas D. Socci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma

Open Access
Maryam Pourmaleki, Caitlin J. Jones, Sabrina D. Mellinghoff, Brian D. Greenstein, Priyadarshini Kumar, Miguel Foronda, Daniel A. Navarrete, Carl Campos, Mikhail Roshal, Nikolaus Schultz, Sohrab P. Shah, Andrea Schietinger, Nicholas D. Socci, Travis J. Hollmann, Ahmet Dogan, Ingo K. Mellinghoff
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3881–3893.
https://doi.org/10.1158/1078-0432.CCR-24-0942
Published: 03 September 2024
View articletitled, Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Open the PDF for Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis

Open Access
Jia Hu, Meera R. Hameed, Narasimhan P. Agaram, Karissa A. Whiting, Li-Xuan Qin, Anthony M. Villano, Rachael B. O'Connor, Julian M. Rozenberg, Sonia Cohen, Katherine Prendergast, Sara Kryeziu, Richard L. White, Jr, Mitchell C. Posner, Nicholas D. Socci, Mrinal M. Gounder, Samuel Singer, Aimee M. Crago
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 450–461.
https://doi.org/10.1158/1078-0432.CCR-23-2313
Published: 17 January 2024
View articletitled, PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
Open the PDF for PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis in another window
Includes: Supplementary data
Journal Articles

Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

Free
Seyram A. Doe-Tetteh, Sabrina Y. Camp, Dalicia Reales, Jett Crowdis, Anne Marie Noronha, Bernadette Wolff, Tina Alano, Jesse Galle, S. Duygu Selcuklu, Agnes Viale, Nicholas D. Socci, Ying L. Liu, William P. Tew, Carol Aghajanian, Marc Ladanyi, Meng Xiao He, Saud H. AlDubayan, Roei David Mazor, Ofer Shpilberg, Oshrat Hershkovitz-Rokah, Jose A. Riancho, Jose L. Hernandez, M. Carmen Gonzalez-Vela, Justin J. Buthorn, Manda Wilson, Amy E. Webber, Mariko Yabe, Kseniya Petrova-Drus, Marc Rosenblum, Benjamin H. Durham, Omar Abdel-Wahab, Michael F. Berger, Mark T.A. Donoghue, Andrew L. Kung, Julia Glade Bender, Neerav N. Shukla, Samuel A. Funt, Ahmet Dogan, Robert A. Soslow, Hikmat Al-Ahmadie, Darren R. Feldman, Eliezer M. Van Allen, Eli L. Diamond, David B. Solit
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (13): 2445–2455.
https://doi.org/10.1158/1078-0432.CCR-22-3247
Published: 05 July 2023
View articletitled, Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
Open the PDF for Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach in another window
Includes: Supplementary data
Journal Articles

Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Available to Purchase
Catherine C. Smith, Aaron D. Viny, Evan Massi, Cyriac Kandoth, Nicholas D. Socci, Franck Rapaport, Matthieu Najm, Juan S. Medina-Martinez, Elli Papaemmanuil, Theodore C. Tarver, Henry H. Hsu, Mai H. Le, Brian West, Gideon Bollag, Barry S. Taylor, Ross L. Levine, Neil P. Shah
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 4003–4011.
https://doi.org/10.1158/1078-0432.CCR-20-3458
Published: 15 July 2021
View articletitled, Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
Open the PDF for Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

Available to Purchase
Alvin P. Makohon-Moore, Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski, Akimasa Hayashi, Collin Tokheim, Priscilla Baez, Rajya Kappagantula, Zachary Kohutek, Vladimir Makarov, Nadeem Riaz, Michael A. Postow, Paul B. Chapman, Rachel Karchin, Nicholas D. Socci, David B. Solit, Timothy A. Chan, Barry S. Taylor, Suzanne L. Topalian, Christine A. Iacobuzio-Donahue
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1516–1525.
https://doi.org/10.1158/1078-0432.CCR-20-2984
Published: 01 March 2021
View articletitled, The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Open the PDF for The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas in another window
Includes: Supplementary data
Journal Articles

Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis

Free
Matthew T. Chang, Alexander Penson, Neil B. Desai, Nicholas D. Socci, Ronglai Shen, Venkatraman E. Seshan, Ritika Kundra, Adam Abeshouse, Agnes Viale, Eugene K. Cha, Xueli Hao, Victor E. Reuter, Charles M. Rudin, Bernard H. Bochner, Jonathan E. Rosenberg, Dean F. Bajorin, Nikolaus Schultz, Michael F. Berger, Gopa Iyer, David B. Solit, Hikmat A. Al-Ahmadie, Barry S. Taylor
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (8): 1965–1973.
https://doi.org/10.1158/1078-0432.CCR-17-2655
Published: 12 April 2018
View articletitled, Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Open the PDF for Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis in another window
Includes: Supplementary data
Journal Articles

Abstract PR16: Multiplatform analysis of paired primary and recurrent well- and dedifferentiated liposarcoma samples defines copy number alterations as dominant drivers of initiation and progression

Free
Aimee M. Crago, Nicholas D. Socci, Li-Xuan Qin, Fatima Wilder, Rachael O'Connor, Amanda Craig, Willem van Houdt, Nils Weinhold, Cyriac Kandoth, Agnes Viale, Cristina Antonescu, Sam Singer
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2_Supplement): PR16.
https://doi.org/10.1158/1557-3265.SARCOMAS17-PR16
Published: 15 January 2018
View articletitled, Abstract PR16: Multiplatform analysis of paired primary and recurrent well- and dedifferentiated liposarcoma samples defines copy number alterations as dominant drivers of initiation and progression
Journal Articles

Abstract A18: A novel targeted capture and massively parallel sequencing platform for systematic discovery of tyrosine kinase fusions in cancer

Free
Juliann Chmielecki, Martin Peifer, Peilin Jia, Nicholas D. Socci, Katherine Hutchinson, Agnes Viale, Zhongming Zhao, Roman K. Thomas, William Pao
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A18.
https://doi.org/10.1158/1078-0432.TCME10-A18
Published: 02 February 2016
View articletitled, Abstract A18: A novel targeted capture and massively parallel sequencing platform for systematic discovery of tyrosine kinase fusions in cancer
Journal Articles

Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

Free
Martin H. Voss, A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying-Bei Chen, Luis F. Cunha, Oguz Akin, Han Liu, Shugaku Takeda, Sasinya N. Scott, Nicholas D. Socci, Agnes Viale, Nikolaus Schultz, Chris Sander, Victor E. Reuter, Paul Russo, Emily H. Cheng, Robert J. Motzer, Michael F. Berger, James J. Hsieh
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (7): 1955–1964.
https://doi.org/10.1158/1078-0432.CCR-13-2345
Published: 31 March 2014
View articletitled, Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
Open the PDF for Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability

Free
Aimee M. Crago, Nicholas D. Socci, Penelope DeCarolis, Rachael O'Connor, Barry S. Taylor, Li-Xuan Qin, Cristina R. Antonescu, Samuel Singer
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1334–1340.
https://doi.org/10.1158/1078-0432.CCR-11-2820
Published: 01 March 2012
View articletitled, Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability
Open the PDF for Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability in another window
Includes: Supplementary data
Journal Articles

Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors

Free
Narasimhan P. Agaram, Michael P. Laquaglia, Berrin Ustun, Tianhua Guo, Grace C. Wong, Nicholas D. Socci, Robert G. Maki, Ronald P. DeMatteo, Peter Besmer, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3204–3215.
https://doi.org/10.1158/1078-0432.CCR-07-1984
Published: 15 May 2008
View articletitled, Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors
Open the PDF for Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors in another window
Journal Articles

A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer

Free
Marta Sanchez-Carbayo, Nicholas D. Socci, Thomas Kirchoff, Nadina Erill, Keneth Offit, Bernard H. Bochner, Carlos Cordon-Cardo
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3215–3220.
https://doi.org/10.1158/1078-0432.CCR-07-0013
Published: 01 June 2007
View articletitled, A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer
Open the PDF for A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer in another window
Journal Articles

Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors

Free
Narasimhan P. Agaram, Peter Besmer, Grace C. Wong, Tianhua Guo, Nicholas D. Socci, Robert G. Maki, Diann DeSantis, Murray F. Brennan, Samuel Singer, Ronald P. DeMatteo, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (1): 170–181.
https://doi.org/10.1158/1078-0432.CCR-06-1508
Published: 02 January 2007
View articletitled, Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors
Open the PDF for Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors in another window
Journal Articles

Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site

Free
Cristina R. Antonescu, Agnes Viale, Lisa Sarran, Sylvia J. Tschernyavsky, Mithat Gonen, Neil H. Segal, Robert G. Maki, Nicholas D. Socci, Ronald P. DeMatteo, Peter Besmer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3282–3290.
https://doi.org/10.1158/1078-0432.CCR-03-0715
Published: 24 May 2004
View articletitled, Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site
Open the PDF for Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site in another window